Nath Bio-Genes Standalone December 2023 Net Sales at Rs 31.74 crore, up 25.46% Y-o-Y
January 19, 2024 / 10:55 IST
Reported Standalone quarterly numbers for Nath Bio-Genes are:Net Sales at Rs 31.74 crore in December 2023 up 25.46% from Rs. 25.30 crore in December 2022.
Quarterly Net Profit at Rs. 3.96 crore in December 2023 up 193.39% from Rs. 1.35 crore in December 2022.
EBITDA stands at Rs. 5.82 crore in December 2023 up 2.65% from Rs. 5.67 crore in December 2022.
Nath Bio-Genes EPS has increased to Rs. 2.09 in December 2023 from Rs. 0.71 in December 2022.
| Nath Bio-Genes shares closed at 206.90 on January 18, 2024 (NSE) and has given -3.59% returns over the last 6 months and 29.56% over the last 12 months. |
| Nath Bio-Genes | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 31.74 | 22.57 | 25.30 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 31.74 | 22.57 | 25.30 | | EXPENDITURE | | Consumption of Raw Materials | 8.35 | 5.66 | 12.14 | | Purchase of Traded Goods | 2.41 | 4.08 | 1.86 | | Increase/Decrease in Stocks | 3.37 | -5.51 | -4.41 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.93 | 7.85 | 4.68 | | Depreciation | 0.76 | 0.76 | 0.67 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.90 | 4.96 | 5.42 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.02 | 4.75 | 4.94 | | Other Income | 0.04 | 0.06 | 0.06 | | P/L Before Int., Excpt. Items & Tax | 5.06 | 4.82 | 5.00 | | Interest | 2.84 | 2.44 | 2.96 | | P/L Before Exceptional Items & Tax | 2.22 | 2.38 | 2.04 | | Exceptional Items | 2.50 | -- | -- | | P/L Before Tax | 4.72 | 2.38 | 2.04 | | Tax | 0.77 | 0.35 | 0.70 | | P/L After Tax from Ordinary Activities | 3.96 | 2.03 | 1.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.96 | 2.03 | 1.35 | | Equity Share Capital | 19.00 | 19.00 | 19.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.09 | 0.85 | 0.71 | | Diluted EPS | 2.09 | 0.85 | 0.71 | | EPS After Extra Ordinary | | Basic EPS | 2.09 | 0.85 | 0.71 | | Diluted EPS | 2.09 | 0.85 | 0.71 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
